Ru(III) Complexes with Lonidamine-Modified Ligands
A series of bifunctional Ru(III) complexes with lonidamine-modified ligands (lonidamine is a selective inhibitor of aerobic glycolysis in cancer cells) was described. Redox properties of Ru(III) complexes were characterized by cyclic voltammetry. An easy reduction suggested a perspective for these a...
Main Authors: | Ilya A. Shutkov, Yulia N. Okulova, Vladimir Yu. Tyurin, Elena V. Sokolova, Denis A. Babkov, Alexander A. Spasov, Yulia A. Gracheva, Claudia Schmidt, Kirill I. Kirsanov, Alexander A. Shtil, Olga M. Redkozubova, Elena F. Shevtsova, Elena R. Milaeva, Ingo Ott, Alexey A. Nazarov |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/24/13468 |
Similar Items
-
New Organometallic Ru(II) Compounds with Lonidamine Motif as Antitumor Agents
by: Ilya A. Shutkov, et al.
Published: (2023-04-01) -
Effect of lonidamine derivatives on the inhibition of transformed cell area expansion
by: Megumi Aoyama, et al.
Published: (2023-07-01) -
Lonidamine Causes Inhibition of Angiogenesis-Related Endothelial Cell Functions
by: Donatella Del Bufalo, et al.
Published: (2004-09-01) -
Lonidamine liposomes to enhance photodynamic and photothermal therapy of hepatocellular carcinoma by inhibiting glycolysis
by: Lei Lei, et al.
Published: (2023-12-01) -
The Potential of Lonidamine in Combination with Chemotherapy and Physical Therapy in Cancer Treatment
by: Yaxin Huang, et al.
Published: (2020-11-01)